MorphoSys AG (MOR)
NASDAQ: MOR
· Real-Time Price · USD
18.96
0.45 (2.43%)
At close: Aug 02, 2024, 10:00 PM
MorphoSys Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 27.54M | 59.08M | 63.8M | 53.17M | 62.32M | 81.67M | 95.7M | 59.44M | 41.5M | 52.9M | 41.24M | 38.2M | 47.19M |
Cost of Revenue | 3.87M | 14.55M | 15.1M | 7.7M | 20.99M | 15.42M | 8.1M | 17.24M | 7.9M | 9.5M | 7.48M | 10.1M | 5.05M |
Gross Profit | 23.67M | 44.52M | 48.7M | 45.46M | 41.33M | 66.25M | 87.6M | 42.2M | 33.6M | 43.4M | 33.76M | 28.1M | 42.14M |
Operating Income | -264.42M | -81.38M | -51M | -50.54M | -69.5M | -40.69M | -29.9M | -55.11M | -67.9M | -325M | -82.36M | -71.4M | -28.6M |
Interest Income | 63.21K | 84.7M | 1.26M | 6.59M | 55M | 164.17M | 70.3M | 6.17M | 10.6M | 49.98M | n/a | 105.3M | 13.9M |
Pretax Income | -311.17M | 46.48M | -119.1M | -72.16M | -44.43M | 502.02M | -123M | -239.01M | -122.5M | -415.2M | -154.01M | 34.4M | -55.1M |
Net Income | -314.96M | 48.27M | -119.6M | -73.97M | -43.89M | 329.44M | -122.9M | -234.99M | -185.32M | -381M | -112.77M | 20.9M | -40.61M |
Selling & General & Admin | 202.94M | -9.16M | 34.9M | 39M | 27.76M | -21.77M | 39.1M | 36.39M | 36.5M | 50.7M | 51.75M | 59M | 38.42M |
Research & Development | 85.15M | 80.31M | 63.2M | 57.01M | 83.07M | 94.01M | 77.8M | 60.92M | 65M | 87M | 64.37M | 40.5M | 32.32M |
Other Expenses | n/a | -832K | n/a | 69.85K | 275.25K | 62.32M | n/a | n/a | n/a | n/a | 757.45K | 300K | n/a |
Operating Expenses | 288.09M | 125.78M | 98.1M | 96.01M | 110.83M | 134.56M | 116.9M | 97.31M | 101.5M | 137.7M | 116.12M | 99.5M | 70.74M |
Interest Expense | 2.83M | n/a | 67.1M | 28.32M | 28.26M | n/a | 167.5M | 185.15M | 62.8M | n/a | 72.67M | 105.34M | 39.69M |
Selling & Marketing Expenses | 18.45M | -52.48M | 19.9M | 22.02M | 16.88M | -63.07M | 23.5M | 24M | 21.9M | 32.5M | 32.37M | 28.5M | 28.17M |
Cost & Expenses | 291.96M | 140.34M | 113.2M | 103.71M | 131.82M | 149.98M | 125M | 114.55M | 109.4M | 147.2M | 123.6M | 109.6M | 75.79M |
Income Tax Expense | -1.58M | -1.69M | 500K | 30.2M | -545K | 172.68M | -100K | -4.02M | 62.82M | -34.4M | -41.23M | 13.5M | -14.49M |
Shares Outstanding (Basic) | 150.47M | 158.41M | 136.68M | 136.67M | 136.66M | 136.66M | 136.62M | 136.6M | 136.6M | 136.56M | 136.53M | 137.01M | 131.04M |
Shares Outstanding (Diluted) | 150.47M | 158.36M | 136.68M | 136.67M | 136.66M | 136.66M | 136.62M | 136.6M | 136.6M | 136.56M | 136.53M | 141.48M | 131.04M |
EPS (Basic) | -2.07 | 0.32 | -0.87 | -0.54 | -0.23 | 2.41 | -0.9 | -1.72 | -0.9 | -2.79 | -0.82 | 0.16 | -0.32 |
EPS (Diluted) | -2.07 | 0.31 | -0.87 | -0.54 | -0.23 | 2.41 | -0.9 | -1.72 | -0.9 | -2.79 | -0.82 | 0.15 | -0.32 |
EBITDA | -263.38M | 26.93M | -50.4M | -40.9M | -13.95M | 230.96M | 43.9M | -50.34M | -59.6M | -92.6M | -78.9M | -71.6M | -13.18M |
EBIT | -308.33M | 50.22M | -53.64M | -45.65M | -2.79M | 203.14M | 44.52M | -53.87M | -59.76M | -323.64M | -81.34M | 139.7M | -16.41M |
Depreciation & Amortization | 1.04M | 2.06M | 2.73M | 2.98M | 2.76M | 2.57M | 2.7M | 2.57M | 2.57M | 2.74M | 2.7M | 2.34M | 2.32M |